Benchling
PrivateLast Round
Series F
Nov 17, 2021
Est. Valuation
$6.1B
Total Funding Raised
$405.05M
Company Overview
Benchling is a life sciences company that provides a lab collaboration platform to enhance the speed and collaboration of research through a suite of integrated applications for designing, sharing, and recording experiments, as well as managing DNA-sequence data in the cloud.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Drug Discovery, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Benchling Comps
Public and private peers based on sector, stage, and business model.
Benchling Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Nov 17, 2021 | ||||
| Series E | Apr 14, 2021 | ||||
| Series D | May 28, 2020 | ||||
| Series C | Jul 24, 2019 | ||||
| Series B | Jun 14, 2018 | ||||
VC Round | Oct 24, 2016 |
Benchling Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | VC Round, Series C, Series A |
| Benchmark Capital | Series E, Series D, Series C |
| SV Angel | Seed, Series A, Accelerator |
| ICONIQ Capital | Series E, Series D |
| F-Prime Capital | Series C, Series B |
| Founders Fund | Seed |
| Thrive Capital | Series E, Series D, Series C, Series A, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Integrated with Seqera Labs and Amazon S3 for R&D lifecycle management.
- Apr 23, 2026
More than half of the top 50 biopharma companies are customers.
Benchling Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Benchling's valuation, stock price, and market status.
